Synthesis and biological evaluation of N9-cis-cyclobutylpurine derivatives for use as cyclin-dependent kinase (CDK) inhibitors

2017 ◽  
Vol 27 (18) ◽  
pp. 4399-4404 ◽  
Author(s):  
Sun Jun Park ◽  
Eunjin Kim ◽  
Miyoun Yoo ◽  
Joo-Youn Lee ◽  
Chi Hoon Park ◽  
...  
INDIAN DRUGS ◽  
2019 ◽  
Vol 56 (05) ◽  
pp. 50-58
Author(s):  
P. V Bhagwanrao ◽  
◽  
P. G. Ingole ◽  
S. R Butle

We report a novel scaffold of 2-phenylpyrido[2,3-d]pyrimidine derivatives designed as structural analogues of dinaciclib. Sixteen derivatives were synthesised and evaluated for their CDK2/5 inhibition activity. Compounds 4-(2-(3-methoxybenzylidene)hydrazineyl)-2-phenylpyrido[2,3-d]pyrimidine (7i) and 4-(2-(3-nitrobenzylidene)hydrazineyl)-2-phenylpyrido[2,3-d]pyrimidine (7n) show promising IC50 and kinase selectivity. These compounds also show moderate anti-proliferative activity in the colon cancer HCT116 and breast cancer MCF7 cell lines. In molecular docking studies with CDK2, compounds 7i and 7nshow binding similar to dinaciclib.


2011 ◽  
Vol 19 (22) ◽  
pp. 6949-6965 ◽  
Author(s):  
Stuart C. Wilson ◽  
Butrus Atrash ◽  
Clare Barlow ◽  
Susan Eccles ◽  
Peter M. Fischer ◽  
...  

2008 ◽  
Vol 6 (9) ◽  
pp. 142-143
Author(s):  
M.A. Martinez-Urbina ◽  
M.A. Vilchis-Reyes ◽  
A. Guzmán Sánchez ◽  
E. Diaz Torres

2008 ◽  
Vol 18 (7) ◽  
pp. 2292-2295 ◽  
Author(s):  
Jinho Lee ◽  
Hwangeun Choi ◽  
Kyoung-Hee Kim ◽  
Shinwu Jeong ◽  
Jong-Wook Park ◽  
...  

2005 ◽  
Vol 15 (9) ◽  
pp. 2221-2224 ◽  
Author(s):  
Ronghui Lin ◽  
Yanhua Lu ◽  
Steven K. Wetter ◽  
Peter J. Connolly ◽  
Ignatius J. Turchi ◽  
...  

ChemInform ◽  
2013 ◽  
Vol 44 (12) ◽  
pp. no-no
Author(s):  
Joannah N'gompaza-Diarra ◽  
Karima Bettayeb ◽  
Nohad Gresh ◽  
Laurent Meijer ◽  
Nassima Oumata

Sign in / Sign up

Export Citation Format

Share Document